Shopping Cart 0
Cart Subtotal
AED 0

Faron Pharmaceuticals Oy (FARN) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 1101

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 2202

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 3303

Details

Summary

Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that develops treatments for unmet medical needs. The company is developing pipeline products with a focus on vascular damage, acute organ traumas and cancer immunotherapy. It offers Clevegen, a humanized Clever-1 antibody, which has the potential to switch immune suppression to immune activation in various conditions, including infectious disease, oncology and vaccine development; and Traumakine, for acute respiratory distress syndrome and rupture of abdominal aorta aneurysm. Traumakine aims to prevent vascular leakage and organ failure under ischemic condition by activating endothelial CD73. The company works in collaboration with academic institutions, pharmaceutical companies and contract research organizations for clinical development programmes. Faron is headquartered in Turku, Finland.

Faron Pharmaceuticals Oy Key Recent Developments

Sep 13,2018: Faron Pharmaceuticals: Interim results for the six months ended 30 June 2018

May 08,2018: Faron Pharmaceuticals: Final Results for the year ended 31 December 2017

This comprehensive SWOT profile of Faron Pharmaceuticals Oy provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Faron Pharmaceuticals Oy including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

READ MORE

Table Of Content

Scope

Table of Contents

Section 1-About the Company

Faron Pharmaceuticals Oy-Key Information

Faron Pharmaceuticals Oy-Overview

Faron Pharmaceuticals Oy-Key Employees

Faron Pharmaceuticals Oy-Key Employee Biographies

Faron Pharmaceuticals Oy-Key Operational Heads

Faron Pharmaceuticals Oy-Major Products and Services

Faron Pharmaceuticals Oy-History

Faron Pharmaceuticals Oy-Company Statement

Faron Pharmaceuticals Oy-Locations And Subsidiaries

Faron Pharmaceuticals Oy-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Faron Pharmaceuticals Oy-Business Description

Faron Pharmaceuticals Oy-Corporate Strategy

Faron Pharmaceuticals Oy-SWOT Analysis

SWOT Analysis-Overview

Faron Pharmaceuticals Oy-Strengths

Faron Pharmaceuticals Oy-Weaknesses

Faron Pharmaceuticals Oy-Opportunities

Faron Pharmaceuticals Oy-Threats

Faron Pharmaceuticals Oy-Key Competitors

Section 3-Company Financial Performance Charts

Faron Pharmaceuticals Oy-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix

Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Note*: Some sections may be missing if data is unavailable for the company


List Of Figure

List of Figures

Faron Pharmaceuticals Oy, Performance Chart

Faron Pharmaceuticals Oy, Ratio Charts


List Of Table

List of Tables

Faron Pharmaceuticals Oy, Key Information

Faron Pharmaceuticals Oy, Key Ratios

Faron Pharmaceuticals Oy, Share Data

Faron Pharmaceuticals Oy, Major Products and Services

Faron Pharmaceuticals Oy, History

Faron Pharmaceuticals Oy, Key Employees

Faron Pharmaceuticals Oy, Key Employee Biographies

Faron Pharmaceuticals Oy, Key Operational Heads

Faron Pharmaceuticals Oy, Other Locations

Faron Pharmaceuticals Oy, Subsidiaries

Faron Pharmaceuticals Oy, Key Manufacturing facilities

Faron Pharmaceuticals Oy, Key Competitors

Faron Pharmaceuticals Oy, SWOT Analysis

Faron Pharmaceuticals Oy, Ratios based on current share price

Faron Pharmaceuticals Oy, Annual Ratios

Faron Pharmaceuticals Oy, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Faron Pharmaceuticals Oy, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Company Profile

Company Profile Title

Summary

Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that develops treatments for unmet medical needs. The company is developing pipeline products with a focus on vascular damage, acute organ traumas and cancer immunotherapy. It offers Clevegen, a humanized Clever-1 antibody, which has the potential to switch immune suppression to immune activation in various conditions, including infectious disease, oncology and vaccine development; and Traumakine, for acute respiratory distress syndrome and rupture of abdominal aorta aneurysm. Traumakine aims to prevent vascular leakage and organ failure under ischemic condition by activating endothelial CD73. The company works in collaboration with academic institutions, pharmaceutical companies and contract research organizations for clinical development programmes. Faron is headquartered in Turku, Finland.

Faron Pharmaceuticals Oy Key Recent Developments

Sep 13,2018: Faron Pharmaceuticals: Interim results for the six months ended 30 June 2018

May 08,2018: Faron Pharmaceuticals: Final Results for the year ended 31 December 2017

This comprehensive SWOT profile of Faron Pharmaceuticals Oy provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Faron Pharmaceuticals Oy including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

READ MORE

Scope

Table of Contents

Section 1-About the Company

Faron Pharmaceuticals Oy-Key Information

Faron Pharmaceuticals Oy-Overview

Faron Pharmaceuticals Oy-Key Employees

Faron Pharmaceuticals Oy-Key Employee Biographies

Faron Pharmaceuticals Oy-Key Operational Heads

Faron Pharmaceuticals Oy-Major Products and Services

Faron Pharmaceuticals Oy-History

Faron Pharmaceuticals Oy-Company Statement

Faron Pharmaceuticals Oy-Locations And Subsidiaries

Faron Pharmaceuticals Oy-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Faron Pharmaceuticals Oy-Business Description

Faron Pharmaceuticals Oy-Corporate Strategy

Faron Pharmaceuticals Oy-SWOT Analysis

SWOT Analysis-Overview

Faron Pharmaceuticals Oy-Strengths

Faron Pharmaceuticals Oy-Weaknesses

Faron Pharmaceuticals Oy-Opportunities

Faron Pharmaceuticals Oy-Threats

Faron Pharmaceuticals Oy-Key Competitors

Section 3-Company Financial Performance Charts

Faron Pharmaceuticals Oy-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix

Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Note*: Some sections may be missing if data is unavailable for the company


List Of Figure

List of Figures

Faron Pharmaceuticals Oy, Performance Chart

Faron Pharmaceuticals Oy, Ratio Charts


List Of Table

List of Tables

Faron Pharmaceuticals Oy, Key Information

Faron Pharmaceuticals Oy, Key Ratios

Faron Pharmaceuticals Oy, Share Data

Faron Pharmaceuticals Oy, Major Products and Services

Faron Pharmaceuticals Oy, History

Faron Pharmaceuticals Oy, Key Employees

Faron Pharmaceuticals Oy, Key Employee Biographies

Faron Pharmaceuticals Oy, Key Operational Heads

Faron Pharmaceuticals Oy, Other Locations

Faron Pharmaceuticals Oy, Subsidiaries

Faron Pharmaceuticals Oy, Key Manufacturing facilities

Faron Pharmaceuticals Oy, Key Competitors

Faron Pharmaceuticals Oy, SWOT Analysis

Faron Pharmaceuticals Oy, Ratios based on current share price

Faron Pharmaceuticals Oy, Annual Ratios

Faron Pharmaceuticals Oy, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Faron Pharmaceuticals Oy, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts